Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra M Jauslin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|December 17, 2011
Identification of the mechanism of action of a glucokinase activator from oral glucose tolerance test data in type 2 diabetic patients based on an integrated glucose-insulin modelPetra M Jauslin, Mats O Karlsson, Nicolas Frey
Journal of Clinical Pharmacology|March 12, 2010
Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetesPetra M Jauslin, Nicolas Frey, Mats O Karlsson
Basic & Clinical Pharmacology & Toxicology|January 7, 2010
An integrated model for the glucose-insulin systemHanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
British Journal of Clinical Pharmacology|March 13, 2020
Exposure-response characterisation of tildrakizumab in chronic plaque psoriasis: Pooled analysis of 3 randomised controlled trialsThomas Kerbusch, Hanbin Li, Russell Wada, et al.
Journal of Clinical Pharmacology|September 4, 2007
An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocationsHanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
Journal of Clinical Pharmacology|October 2, 2007
An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabeticsPetra M Jauslin, Hanna E Silber, Nicolas Frey, et al.
Journal of Clinical Pharmacology|May 16, 2024
Exposure-Response Analyses for Belzutifan to Inform Dosing Considerations and LabelingDhananjay D Marathe, Petra M Jauslin, Huub Jan Kleijn, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2023
Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labelingDhananjay D Marathe, Petra M Jauslin, Huub Jan Kleijn, et al.
British Journal of Clinical Pharmacology|January 15, 2026
Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitisFloris Fauchet, Anna Largajolli, Petra M Jauslin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|December 17, 2011
Identification of the mechanism of action of a glucokinase activator from oral glucose tolerance test data in type 2 diabetic patients based on an integrated glucose-insulin modelPetra M Jauslin, Mats O Karlsson, Nicolas Frey
Journal of Clinical Pharmacology|March 12, 2010
Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetesPetra M Jauslin, Nicolas Frey, Mats O Karlsson
Basic & Clinical Pharmacology & Toxicology|January 7, 2010
An integrated model for the glucose-insulin systemHanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
British Journal of Clinical Pharmacology|March 13, 2020
Exposure-response characterisation of tildrakizumab in chronic plaque psoriasis: Pooled analysis of 3 randomised controlled trialsThomas Kerbusch, Hanbin Li, Russell Wada, et al.
Journal of Clinical Pharmacology|September 4, 2007
An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocationsHanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
Journal of Clinical Pharmacology|October 2, 2007
An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabeticsPetra M Jauslin, Hanna E Silber, Nicolas Frey, et al.
Journal of Clinical Pharmacology|May 16, 2024
Exposure-Response Analyses for Belzutifan to Inform Dosing Considerations and LabelingDhananjay D Marathe, Petra M Jauslin, Huub Jan Kleijn, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2023
Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labelingDhananjay D Marathe, Petra M Jauslin, Huub Jan Kleijn, et al.
British Journal of Clinical Pharmacology|January 15, 2026
Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitisFloris Fauchet, Anna Largajolli, Petra M Jauslin, et al.
Pageof 1